The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public notification regarding the discovery of counterfeit Chloroquine Phosphate tablets in circulation.
In an official statement released, NAFDAC indicated that the falsified product, found lacking Active Pharmaceutical Ingredient (API), was procured from an informal dispensary in Jos, Plateau State.
Despite bearing a counterfeit NAFDAC Registration Number (04-8769), it is crucial to emphasize that this product is not registered by NAFDAC and does not feature in its database of authorized pharmaceuticals.
NAFDAC has initiated nationwide surveillance, urging all state offices to monitor and confiscate any batches of the fraudulent medication.
NAFDAC further advised the public to cease sales or usage of these counterfeit tablets and promptly surrender any stock to the nearest NAFDAC office for further investigation and disposal.
The statement read, “NAFDAC is notifying the public of the sale of a falsified brand of Chloroquine Phosphate tablets.
The fake product was discovered and purchased from an informal dispensary in Jos, Plateau State, Nigeria. TLC screening conducted on the tablets revealed that the product contains no Active Pharmaceutical Ingredient.
Though the falsified product was observed to carry NAFDAC Registration Number 04-8769, it should be noted that the product is not registered by NAFDAC and is not in the NAFDAC database of registered products.
This product may have been distributed to several parts of the country through legal and illegal channels.
Consequently, NAFDAC has directed all state offices to conduct surveillance and mop up all violating batches of the product.
Members of the public in possession of the above-mentioned product are advised to discontinue sale or use and submit stock to the nearest NAFDAC office.”
By Ruth Sekyi – Public Sector Global
